Critical Congenital Heart Disease Newborn Screening Demonstration Program
Because Every Baby Deserves a Healthy Start
Congenital heart defects are the most common group of birth defects, affecting 9 in 1000 newborns. Critical congenital heart diseases (CCHD) are those requiring surgery or catheter intervention in the first year of life. CCHDs remain one of the most significant causes of infant death in the United States.
Newborn Pulse Oximetry Screening for CCHD
The Michigan Department of Community Health (MDCH) is implementing a demonstration program to assess the feasibility of screening all Michigan newborns for critical congenital heart disease using pulse oximetry prior to hospital discharge. Many of Michigan's birthing centers have already begun to include pulse oximetry screening as standard practice for all newborns. Some hospitals have volunteered to participate in a pilot project for standardized screening reporting and implementation using Michigan's CCHD Screening Algorithm.
CCHD NEWS & UPDATES
MI CCHD Screening Mandate Status
Screening for critical congenital heart disease (CCHD) using pulse oximetry has been added to the mandated newborn screening panel in Michigan. Starting April 1, 2014 screening will be required for all newborns. Michigan will join 31 other states that require screening for CCHD.
MDCH CCHD Press Release
CCHD Mandate Letter to Hospital Administrators
November 2013 letter from MDCH Director, James Haveman, announcing the addition of Critical Congenital Heart Disease to Michigan's mandatory screening panel.
CCHD Screening- DATA REPORTING
When the mandate takes effect April 1, 2014 hospitals will be required to electronically submit CCHD screening data to the MDCH Newborn Screening Program.
For additional information on data
reporting contact Karen Andruszewski
Congenital Heart Defect Awareness Week
February 7-14, 2014 -Click HERE for more information and awareness week materials.
Michigan CCHD in the Media
MDCH* CCHD Team Members
*Michigan Department of Community Health
Lifecourse Epidemiology & Genomics Division
The Michigan Critical Congenital Heart Disease Newborn Screening Demonstration Program is supported through federal funding by the Health Resources and Services Administration (HRSA).
Pulse oximetry photos courtesy of Massimo corporation.
Updated December 2, 2013